Diabetes
Explore diabetes
Explore obesity
Explore growth-related disorders
Explore rare bleeding disorders
Explore rare renal disorders
Explore hormone replacement therapy
Medical Information | Non-US Health Care Professionals
Account Settings
Sign Out
Sign In | Create Account
Diabetes
Time in Range (TIR)
Time in Range (TIR)
  • Overview
    • What is Time in Range (TIR)?
    • Why TIR matters
    • Clinical guidance and targets
    • How to use TIR in clinical practice
    • Understanding the AGP
    • Getting started with TIR
    • Using TIR to create action
  • Continuous glucose monitoring
  • Expert insights
  • Patient stories
healthcare professional icon

LEADING EXPERTS ON TIME IN RANGE (TIR)

Perspectives on TIR

Dr Alice Cheng on TIR

TIR HCP Educational Content: Time in Range KOL Video of Dr. Cheng
(10:46)

Dr Alice Cheng explains why the useful metric, TIR, is a complement to the already established hemoglobin A1c (HbA1c).

Healthcare professional has received a fee from Novo Nordisk Inc. for her participation.

About Dr Alice Cheng

Dr Alice Cheng is an endocrinologist at Trillium Health Partners in Mississauga and St. Michael’s Hospital in Toronto and an Associate Professor in the Department of Medicine at the University of Toronto. For her contributions to diabetes care, she has received a Certificate of Recognition from the Ontario College of Family Physicians.


Dr Richard Bergenstal on Time in Range

TIR HCP Educational Content: Time in Range KOL Video of Dr. Bergenstal
(10:39)

Dr Richard Bergenstal explains how CGM data and the ambulatory glucose profile (AGP) report can be interpreted and used in a clinical setting.

Healthcare professional has received a fee from Novo Nordisk Inc. for his participation.

About Dr Richard Bergenstal

Dr Richard Bergenstal is an endocrinologist and Executive Director of the International Diabetes Center in Minneapolis, Minnesota. Two areas of recent focus include standardizing glucose data reports utilizing the AGP and effective strategies for implementing continuous glucose monitoring (CGM) and hybrid closed-loop therapy into clinical practice. 

Diabetes
Explore diabetes
Explore obesity
Explore growth-related disorders
Explore rare bleeding disorders
Explore rare renal disorders
Explore hormone replacement therapy

novoMEDLINK™ is a trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.

Terms of Use | Privacy Notice | Consumer Health Privacy Notice | Cookie Notice | Privacy Request | Contact Us |
novonordisk-us.com    
© 2023 Novo Nordisk All rights reserved. US21HCP00098 November 2023

Quick links

Request medication samples

Diabetes treatment guidelines

Patient savings card offer

Patient support program